Morpholine as ubiquitous pharmacophore in medicinal chemistry: Deep insight into the structure-activity relationship (SAR)

被引:143
|
作者
Kumari, Archana [1 ,3 ]
Singh, Rajesh K. [2 ]
机构
[1] Rayat Bahra Inst Pharm, Dept Pharmaceut Chem, Nangal Shahidan 146104, Punjab, India
[2] Shivalik Coll Pharm, Dept Pharmaceut Chem, Nangal 140126, Punjab, India
[3] IK Gujral Punjab Tech Univ, Fac Pharm, Jalandhar, Punjab, India
关键词
Morpholine; Pharmacophore; Structure-activity relationship (SAR); Pharmacokinetic; Pharmacological profile; DEPENDENT PROTEIN-KINASE; PHOSPHATIDYLINOSITOL 3-KINASE PI3K; IN-VITRO METABOLISM; (PI3K)/MAMMALIAN TARGET; BIOLOGICAL EVALUATION; SELECTIVE INHIBITOR; ASYMMETRIC-SYNTHESIS; ANTIFUNGAL AGENTS; MAMMALIAN TARGET; SCHIFF-BASES;
D O I
10.1016/j.bioorg.2020.103578
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Morpholine is a versatile moiety, a privileged pharmacophore and an outstanding heterocyclic motif with wide ranges of pharmacological activities due to different mechanisms of action. The ability of morpholine to enhance the potency of the molecule through molecular interactions with the target protein (kinases) or to modulate the pharmacokinetic properties propelled medicinal chemists and researchers to synthesize morpholine ring by the efficient ways and to incorporate this moiety to develop various lead compounds with diverse therapeutic activities. The present review primarily focused on discussing the most promising synthetic leads containing morpholine ring along with structure-activity relationship (SAR) to reveal the active pharmacophores accountable for anticancer, anti-inflammatory, antiviral, anticonvulsant, antihyperlipidemic, antioxidant, antimicrobial and antileishmanial activity. This review outlines some of the recent effective chemical synthesis for morpholine ring. The review also highlighted the metabolic liability of some clinical drugs containing this nucleus and various researches on modified morpholine to enhance the metabolic stability of drugs as well. Drugs bearing morpholine ring and those under clinical trials are also mentioned with the role of morpholine and their mechanism of action. This review will provide the necessary knowledge base to the medicinal chemists in making strategic structural changes in designing morpholine derivatives.
引用
收藏
页数:33
相关论文
共 50 条
  • [41] Medicinal Chemistry of Anti-HIV-1 Latency Chemotherapeutics: Biotargets, Binding Modes and Structure-Activity Relationship Investigation
    Wang, Yan-Kai
    Wei, Long
    Hu, Wei
    Yu, Pei-Xia
    Li, Zhong
    Yu, Hai-Peng
    Li, Xun
    MOLECULES, 2023, 28 (01):
  • [42] Medicinal perspective of quinazolinone derivatives: Recent developments and structure-activity relationship studies
    Wahan, Simranpreet K.
    Sharma, Bharti
    Chawla, Pooja A.
    JOURNAL OF HETEROCYCLIC CHEMISTRY, 2022, 59 (02) : 239 - 257
  • [43] Medicinal Perspective of Indole Derivatives: Recent Developments and Structure-Activity Relationship Studies
    Kumar, Devendra
    Sharma, Sahil
    Kalra, Sourav
    Singh, Gurpreet
    Monga, Vikramdeep
    Kumar, Bhupinder
    CURRENT DRUG TARGETS, 2020, 21 (09) : 864 - 891
  • [44] Chemistry and structure-activity of indirubins
    Merz, Karl-Heinz
    Eisenbrand, Gerhard
    INDIRUBIN, THE RED SHADE OF INDIGO, 2006, : 135 - +
  • [45] Biotransformation of curcumin and structure-activity relationship (SAR) of its analogues: A systematic review
    Aminudin, Nurul Iman
    Amran, Nurul Aqilah
    Abidin, Zaima Azira Zainal
    Susanti, Deny
    BIOCATALYSIS AND BIOTRANSFORMATION, 2023, 41 (01) : 1 - 14
  • [46] Structure-activity relationship (SAR) analysis of a family of steroids acutely controlling steroidogenesis
    Midzak, Andrew
    Rammouz, Georges
    Papadopoulos, Vassilios
    STEROIDS, 2012, 77 (13) : 1327 - 1334
  • [47] The structure-activity relationship (SAR) of and novel molecular mechanisms for ginsenosides as anticancer agents
    Wang, Wei
    Chen, Haiyan
    Zhao, Yuqing
    Wang, Hui
    Zhang, Ruiwen
    CANCER RESEARCH, 2006, 66 (08)
  • [48] Weight gain and loss: A structure-activity relationship (SAR) study across the psychotropics
    Szekely, T
    Heller, MB
    BIOLOGICAL PSYCHIATRY, 2003, 53 (08) : 80S - 81S
  • [49] Tyrosinase inhibitors from Rhododendron collettianum and their structure-activity relationship (SAR) studies
    Ahmad, VU
    Ullah, F
    Hussain, J
    Farooq, U
    Zubair, M
    Khan, MTH
    Choudhary, MI
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2004, 52 (12) : 1458 - 1461
  • [50] STRUCTURE-ACTIVITY RELATIONSHIP (SAR) AND PHARMACOLOGICAL PECULIARITIES OF NEW SYNTHETIC CONGENERS OF TETRAHYDROCANNABINOL
    LOEWE, S
    ADAMS, R
    FEDERATION PROCEEDINGS, 1947, 6 (01) : 352 - 352